- Home
- PZZA vs CDNA Comparison
PZZA vs CDNA Comparison
Compare PZZA & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PZZA
- CDNA
- Stock Information
- Founded
- PZZA 1984
- CDNA 1998
- Country
- PZZA United States
- CDNA United States
- Employees
- PZZA N/A
- CDNA N/A
- Industry
- PZZA Restaurants
- CDNA Medical Specialities
- Sector
- PZZA Consumer Discretionary
- CDNA Health Care
- Exchange
- PZZA Nasdaq
- CDNA Nasdaq
- Market Cap
- PZZA 1.1B
- CDNA 1.0B
- IPO Year
- PZZA 1993
- CDNA 2014
- Fundamental
- Price
- PZZA $49.88
- CDNA $19.49
- Analyst Decision
- PZZA Buy
- CDNA Buy
- Analyst Count
- PZZA 12
- CDNA 6
- Target Price
- PZZA $51.36
- CDNA $30.33
- AVG Volume (30 Days)
- PZZA 1.4M
- CDNA 982.3K
- Earning Date
- PZZA 08-07-2025
- CDNA 07-30-2025
- Dividend Yield
- PZZA 3.66%
- CDNA N/A
- EPS Growth
- PZZA 4.47
- CDNA N/A
- EPS
- PZZA 2.37
- CDNA 1.07
- Revenue
- PZZA $2,063,780,000.00
- CDNA $346,421,000.00
- Revenue This Year
- PZZA $4.30
- CDNA $13.31
- Revenue Next Year
- PZZA $3.68
- CDNA $15.46
- P/E Ratio
- PZZA $21.22
- CDNA $17.54
- Revenue Growth
- PZZA N/A
- CDNA 25.92
- 52 Week Low
- PZZA $30.16
- CDNA $14.09
- 52 Week High
- PZZA $60.75
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- PZZA 63.04
- CDNA 57.30
- Support Level
- PZZA $47.41
- CDNA $18.64
- Resistance Level
- PZZA $49.50
- CDNA $19.84
- Average True Range (ATR)
- PZZA 1.79
- CDNA 0.83
- MACD
- PZZA -0.39
- CDNA -0.05
- Stochastic Oscillator
- PZZA 53.35
- CDNA 69.64
About PZZA Papa John's International Inc.
Papa John's is one of the largest players in the global QSR, or quick-service restaurant, pizza market, boasting more than 6,000 restaurants across nearly 50 countries at the end of 2024. The firm operates a predominantly franchised system, owning 9% of its restaurants and generating revenue from franchise royalties, sales of pizza and related products at its company-owned stores, and sales from its commissary supply chain. The firm is the fourth-largest limited-service pizza chain globally and third in the US (Euromonitor International), with a sizable presence in the UK, China, South Korea, and Chile.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.